维普中文期刊产品整合服务
15篇 您的检索式:作者名="Witzig J"
    题名 作者 年代 出处 被引量
1Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience显示文摘Phil A Hart Mark D Topazian Thomas E Witzig Jonathan E Clain Ferga C Gleeson Robin R Klebig Michael J Levy Randall K Pearson Bret T Petersen Thomas C Smyrk Aravind Sugumar Naoki Takahashi Santhi S Vege Suresh T Chari 2013Gut2013,,11:2
2Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience显示文摘Phil A Hart Mark D Topazian Thomas E Witzig Jonathan E Clain Ferga C Gleeson Robin R Klebig Michael J Levy Randall K Pearson Bret T Petersen Thomas C Smyrk Aravind Sugumar Naoki Takahashi Santhi S Vege Suresh T Chari 2013Gut2013,,11:2
3Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity显示文摘Mathew P Ahmann G J Witzig T E 1995Br J Haematol1995,90,:1
4Intratumoral CD4 ( + )CD25 ( + ) regulatory T-cell-mediated suppression of infiltrating CD4( + ) T cells in B-cell non-Hodgkin lymphoma 显示文摘Yang ZZ Novak A J Stenson MJ Witzig TE Ansell SM 2006Blood2006,107,9:1
5An international phase Ⅱ trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma显示文摘Witzig TE Vose M J Luigi Zinzani P 2011Ann Oncol Jan2011,10,3:1
6Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome 显示文摘Novak A J Grote DM Stenson M Ziesmer SC Witzig TE Habermann TM 2004Blood2004,104,8:1
7An interna- tional phase II trial of single-agent lenalidomide for re- lapsed or refractory addressive B-Cell non-Hodgkin's lymphoma显示文摘Witzig T E Vose J M Zinzani P L 2011Ann Oncol2011,22,7:1
8An inter-national phase If trial of single-agent lenalidomide for re-lapsed or refractory aggressive B-Cell non-Hodgkin lym-phoma显示文摘WITZIG T E VOSE J M ZINZANI P L 2011Ann Oncol2011,22,:1
9Assessment of toluene/ biphenyl dioxygenase gene diversity in benzene-polluted soils: links between benzene biodegradation and gene similar to those encoding isopropylbenzene dloxygenases 显示文摘Witzig R Junca H Hecht H J 2006Applied and Environmental Microbiology2006,72,5:1
10A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and yttrium- 90 ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma显示文摘Witzig TE Wiseman GA Maurer M J 2013Am JHematol2013,88,7:1
11Waldwirkung und Hochwasserschutz-eine stand6 rtlich differenzierte Betrachtung显示文摘Witzig J Badoux A Hegg C 2004Forst und Holz2004,59,10:1
12Peripheral blood monoclonal plasma cell as a predictor of survival in patients with multiple myeloma显示文摘WITZIG T E GERTA M A LUST J A 1996Blood J1996,83,:1
13Durable responses after lena- lidomide oral monotherapy in patients with relapsed or refractory (R/R) aggressivenon-Hodgkin' s lymphoma (a-NHL) : results from an international phase 2 study ( CC-5013-NHL4)03 ) 显示文摘Witzig T Vose J Zinzani P 2009Blood2009,114,:1
14Rapid, low- technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay 显示文摘Franzblau S G Witzig R S McLaughlin J C et aI 1998JClinMicrobiol1998,36,2:1
15Treatment of benign orbital pseudolymphomas with the monoclonal anti-CD20 antibody rituximab显示文摘Witzig TE Inwards D J Habermann TM 2007Mayo Clin Proc2007,82,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费